This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Aesculus Bio Aps. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Dirk Ehmann: Innovator in Antimicrobial Peptide Therapy
Introduction
Dirk Ehmann is a notable inventor based in Tübingen, Germany. He has made significant contributions to the field of antimicrobial therapy through his innovative research and development of peptides. His work focuses on enhancing the modulation of microbiomes in various bodily surfaces.
Latest Patents
Dirk Ehmann holds a patent for "Defensin fragments for use in therapy or prophylaxis." This invention relates to new peptides derived from HD-5 or HNP-4 that exhibit antimicrobial activity. These peptides are designed for use in modulating the microbiome of intestines, lungs, skin, mouth, eyes, ears, vagina, or other bodily surfaces. Additionally, they can serve as antimicrobial agents in humans and other mammals, as well as in medicaments containing these peptides.
Career Highlights
Ehmann is currently associated with Aesculus Bio Aps, where he continues to advance his research in antimicrobial therapies. His work has the potential to impact various medical fields by providing new solutions for infection control and microbiome management.
Collaborations
Dirk collaborates with Jan Wehkamp, a fellow researcher, to further explore the applications of his patented peptides in therapeutic settings.
Conclusion
Dirk Ehmann's innovative work in antimicrobial peptide therapy showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic options in the fight against infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile